Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular Drugs [version 3; peer review: 2 approved, 1 approved with reservations]
Background As lung cancer treatment has progressed, there has been an increase in awareness of the short- and long-term adverse effects of targeted cancer therapies of tyrosine kinase inhibitors, particularly cardiovascular toxicities. Methods The current study assessed the potential drug-drug inter...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
F1000 Research Ltd
2026-02-01
|
| Serier: | F1000Research |
| Fag: | |
| Online adgang: | https://f1000research.com/articles/14-309/v3 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|